Prevalence

Viral Vector and Plasmid DNA Technologies and Global Market Analysis - A USD 7.1 Billion Market by 2028, Expansion of Biotechnological Applications Fuels Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 2, 2024
Cardiology, Biotechnology, Health, Pharmaceutical, Oncology, Health Technology, Other Science, Research, Infectious Diseases, Genetics, Science, AAV, Transfection, QC, HSV, Acute lymphoblastic leukemia, Growth, Prevalence, Cell, Incidence, ALL, Tissue, DNA, Mortality, Virus, Cancer, Human, Infection, World Health Organization, Neoplasm, Immunization, Safety, WHO, Therapy, Inosine pranobex, USD, DSM-IV codes, Tisagenlecleucel, Vaccine

The rising incidence and prevalence rate of cancer is considered a key factor in the growth of the global viral vector and plasmid DNA technologies market.

Key Points: 
  • The rising incidence and prevalence rate of cancer is considered a key factor in the growth of the global viral vector and plasmid DNA technologies market.
  • However, regulatory challenges, vector characterization, and QC testing, and manufacturing challenges have restrained growth in the global viral vector and plasmid DNA technologies market.
  • The global viral vector and plasmid DNA technologies market is segmented based on the product, application, and end-user.
  • Based on the product, the global viral vector and plasmid DNA technologies market further is analyzed into plasmid DNA and viral vectors.

A native iOS App for First Responders: ESO Unveils Exciting Addition to Electronic Health Record Offering

Retrieved on: 
Tuesday, April 2, 2024
Apps, Applications, Technology, Law Enforcement, Emergency Services, Health Technology, Public Policy, Government, Software, General Health, Health, Data Management, Consumer Electronics, Dark, IPad, Documentation, Device, Prevalence, Patient, Hospital, IOS, ESO, Ecosystem, EHR, Nursing care plan, EMS, Emergency medical services, Video game

This addition to ESO's suite of offerings is poised to change the user experience for first responders.

Key Points: 
  • This addition to ESO's suite of offerings is poised to change the user experience for first responders.
  • The iOS app, slated for release this winter, will complement ESO's existing EHR Web and EHR Windows Mobile products, providing users with a seamless and intuitive interface for Apple iOS devices.
  • In an evolving landscape where market trends and customer demographics continually shift, ESO remains committed to staying ahead of the curve.
  • The decision to develop a native iOS app stems from a strategic initiative to meet the growing demand for more user-friendly, cost-effective, and versatile solutions in the field.

Global Medical Adhesives & Sealants Market Report 2024 - Wide Array of Solutions and Application Areas Offered by Soft-Skin Adhesives Facilitating Market Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, April 1, 2024
Medical Supplies, Health, Blood pressure, Adhesive, Dentistry, Growth, Prevalence, Vital signs, Patient, Conditional sentence, Radiation, Palliative care, Metal, Bacteria, Instrument, Electrode, Fibrin, Chronic radiation syndrome, Skin, Collagen, EKG, USB On-The-Go, Cosmetics, Acrylic

The "Global Medical Adhesives & Sealants Market - Resin Types, Applications and End-use Sectors" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Medical Adhesives & Sealants Market - Resin Types, Applications and End-use Sectors" report has been added to ResearchAndMarkets.com's offering.
  • The growth in demand for soft-skin adhesives has been made possible by the wide variety of their applications in the medical, pharmaceutical and personal care areas.
  • Soft-skin adhesives find application in a range of medical areas, which comprise skin therapies, wound dressing and wearable medical devices, providing further impetus to demand for them.
  • The range of applications for adhesives and sealants the medical sector includes the areas of dentistry & cosmetics, internal & external surgery and medical devices & equipment.

Global Disposable Gloves Market Outlook & Forecast 2024-2029, Featuring Key Vendors Ansell, Hartalega Holdings, Kossan Rubber Industries, Rubberex, Supermax, Top Glove and UG Healthcare - ResearchAndMarkets.com

Retrieved on: 
Monday, April 1, 2024
Manufacturing, Other Manufacturing, Health, Chemicals, Plastics, Medical Supplies, Hospital, Research, Sanitation, Oil, Dentistry, Growth, Prevalence, Face, Agriculture, Mechanics, Beauty, COVID-19, Global health, Patient, Kossan Rubber Industries, Electronics, Health care, Latex, Laboratory, Surgeon, Infection, LaTeX, Water, Traction, Hygiene, Safety, B2B, Cosmetics, Neoprene, USD, Dentist, Medical device

The global disposable gloves market is characterized by dynamic and competitive forces shaped by supply and demand factors.

Key Points: 
  • The global disposable gloves market is characterized by dynamic and competitive forces shaped by supply and demand factors.
  • Prominent manufacturers include Ansell, Hartalega Holdings, Kossan Rubber Industries, Rubberex, Supermax, Top Glove, and UG Healthcare.
  • The global disposable gloves market, mainly fueled by the rising demand for nitrile gloves, stands at a pivotal juncture.
  • Disposable gloves have become indispensable in healthcare, food processing, manufacturing, and other sectors, shaping a robust market landscape in the region.

Global Vitamin A Market Analysis, Size, Trends and Forecasts to 2029 - A US$745.84 Million Market by 2029, with Expected CAGR of 5.26% Over 2024-2029 - ResearchAndMarkets.com

Retrieved on: 
Monday, April 1, 2024
Fitness & Nutrition, Health, Element, Meat, Urbanization, Growth, Vitamin A, Prevalence, Poultry, Application, Dietary supplement, Livestock, Eye, Skin, Nature, Aquaculture, Safety, Cosmetics, Vitamin A deficiency, Ageing

The global vitamin A market value stood at US$548.36 million in 2023 and is expected to reach US$745.84 million by 2029.

Key Points: 
  • The global vitamin A market value stood at US$548.36 million in 2023 and is expected to reach US$745.84 million by 2029.
  • The market is expected to grow at a CAGR of 5.26% over the projected period of 2024-2029.
  • The rising demand for functional foods, fortified with essential nutrients including vitamin A, has also contributed to market growth.
  • Overall, Asia Pacific's dynamic market landscape positions it as a key player in the global vitamin A sector.

Global and Regional Industrial Batteries Market Analysis and Forecasts, 2023-2033: Advancements in Telecommunication Sector with Focus on Sustainability and Efficiency Spearheading Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, April 1, 2024
Technology, Batteries, Innovation, Wind, Automation, Region, Research, Growth, Prevalence, Paramount, Safety, Mobile phone

The "Industrial Batteries Market - A Global and Regional Analysis: Focus on Battery Type, End User, and Country-Level Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Industrial Batteries Market - A Global and Regional Analysis: Focus on Battery Type, End User, and Country-Level Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • Industrial batteries play a crucial role in guaranteeing a consistent power source for vital systems, minimizing downtime, and improving overall operational efficiency.
  • Innovations like solid-state batteries and advanced chemical compositions play a crucial role in the overall expansion and competitiveness of the industrial batteries market.
  • What are the major patents filed by the companies active in the global industrial batteries market?

Global Transdermal Medical Patch Market Analysis and Forecast to 2029: Growing Number of Smokers, Rising use for Insulin Delivery and Upswing in Hormonal Deficiencies Drives Demand - ResearchAndMarkets.com

Retrieved on: 
Monday, April 1, 2024
Medical Supplies, Retail, Health, Tobacco, General Health, Pharmaceutical, Biotechnology, Hypersensitivity, Plasma, Obesity, Growth, Prevalence, Rheumatoid arthritis, Application, Incidence, Diabetes, Patient, Pharmacy, Conditional sentence, Chronic pain, Stroke, Hospital, Smoker, Cancer, Nature, Migraine, Distribution, Arthritis, Nausea, Diabetic neuropathy, Smoking, Skin, Pain management, Pain, Allergy, Market, Vomiting, Osteoarthritis, Ageing, Pharmaceutical industry

The "Global Transdermal Medical Patch Market: Analysis By Type, By Application, By Distribution Channel, By Region Size & Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Transdermal Medical Patch Market: Analysis By Type, By Application, By Distribution Channel, By Region Size & Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • The global transdermal medical patch market was valued at US$7.88 billion in 2023 and is expected to reach US$10.33 billion by 2029.
  • The global transdermal medical patch market is highly competitive in nature, characterized by fierce competition among industry leaders vying to expand their market presence.
  • The key players in the global transdermal medical patch market are:

Global Cell Counting Market to Hit $15.72 Billion by 2029, Fueled by Advancements in Cell Biology and Therapy - ResearchAndMarkets.com

Retrieved on: 
Friday, March 29, 2024
Research, Technology, University, Genetics, Artificial Intelligence, Education, Science, Nanotechnology, Biotechnology, Stem Cells, Other Technology, Health, Other Science, Automation, Quality control, Interdisciplinarity, Acute lymphoblastic leukemia, Growth, Prevalence, Application, Novartis, Patient, Conditional sentence, Cell biology, Lung, Concha bullosa, Hospital, Artificial intelligence, National Cancer Institute, AI, Regenerative medicine, Duchenne muscular dystrophy, Therapy, DEB, Miniaturization, Sarepta Therapeutics, CGT, FDA, DMD, Tisagenlecleucel, PDUFA, Pharmaceutical industry

The global cell counting market was valued at US$9.98 billion in 2023 and is expected to reach US$15.72 billion by 2029.

Key Points: 
  • The global cell counting market was valued at US$9.98 billion in 2023 and is expected to reach US$15.72 billion by 2029.
  • Advancements in cell biology, biotechnology, and medical research are driving demand for precise cell counting, especially with the rise of personalized medicine and regenerative therapies.
  • PDUFA dates for therapies could translate into an order book boost for the cell counting players in the market, resulting in market growth.
  • The global cell counting market is consolidated, with top five players holding approximately 70% share of the market.

$3.8 Billion MRSA Drugs Markets by Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region - Global Forecast to 2032 - ResearchAndMarkets.com

Retrieved on: 
Friday, March 29, 2024
Health, Pharmaceutical, MRSA, Urbanization, Growth, Prevalence, Fungal infection, Pharmacy, Research, Bacteria, Genetically modified bacteria, Tetracycline, Infection, Skin, Lipopeptide, Market, Administration, CA-MRSA, Pharmaceutical industry

The "MRSA Drugs Market by MRSA Type, Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "MRSA Drugs Market by MRSA Type, Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.
  • Moreover, the augmenting awareness regarding different forms of bacterial infection is leading to a higher uptake of MRSA drugs.
  • The report has provided a detailed breakup and analysis of the MRSA drugs market based on the MRSA type.
  • The report has provided a detailed breakup and analysis of the MRSA drugs market based on the route of administration.

70%+ of Payers and Providers Anticipate Greatest Impact of Gen AI on Health Outcomes and Member Experience, According to HFS Research and Cognizant Report

Retrieved on: 
Thursday, March 28, 2024
Professional Services, Health, Technology, Data Analytics, General Health, Artificial Intelligence, Research, Prevalence, Partnership, Cognizant, Artificial intelligence, AI, Life expectancy, Statistics, Investment, HFS, Machine learning

C-suite (CXOs) and senior leaders at 350 US health plans and health systems were asked for their insights to explore the impact of vertical integration and generative AI (gen AI) on payer-provider friction and consumer experience and engagement.

Key Points: 
  • C-suite (CXOs) and senior leaders at 350 US health plans and health systems were asked for their insights to explore the impact of vertical integration and generative AI (gen AI) on payer-provider friction and consumer experience and engagement.
  • Lack of gen AI skills―programming, statistics, machine learning, data processing and visualization, and certain domain understanding―is a top challenge cited by payers and providers in adopting gen AI.
  • While leadership across healthcare is keen on making progress on gen AI, senior leaders and practitioners often express reservations about true impact.
  • “The report highlights the disconnect between payers and providers and its impact on patient engagement and health outcomes,” said Patricia Birch SVP and Chief Strategy Officer for Cognizant Health Sciences and report co-author.